Ortin Laboratories Limited
BSE: ORTINLAABS
BSE
22.34
-0.51 (-2.23%)
Prev Close
22.85
Open Price
23.31
Volume
14,101
Today Low / High
22.27 / 23.31
52 WK Low / High
22.27 / 23.31
Range
21 - 23
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 22.34, reflecting a change of -0.51 (-2.2319%). The expected target range on the BSE is 21 - 23. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Ortin Laboratories Limited Graph
Ortin Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ortin Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 22.34, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 22.34 | 22.56 | 20.31 - 24.82 |
| 22.79 | 18.23 - 27.34 | ||
| 23.01 | 16.11 - 29.91 | ||
| Bearish Scenario | 22.34 | 22.12 | 19.90 - 24.33 |
| 21.89 | 17.51 - 26.27 | ||
| 21.67 | 15.17 - 28.17 |
Overview of Ortin Laboratories Limited
ISIN
INE749B01020
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
0
Market Cap
0
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 6.00 Cr | 4.67 Cr | 1.32 Cr | 0.2208 | 0.00 Cr | 0.00 Cr | 0.27 Cr | -0.09 Cr | -0.12 | 0.52 Cr | -0.0156 |
| 2022-03-31 | 8.23 Cr | 6.08 Cr | 2.15 Cr | 0.2610 | 0.00 Cr | 0.00 Cr | 0.25 Cr | -0.40 Cr | -0.49 | 0.54 Cr | -0.0485 |
| 2021-03-31 | 8.16 Cr | 5.61 Cr | 2.56 Cr | 0.3132 | 0.00 Cr | 0.00 Cr | 0.96 Cr | 0.95 Cr | 1.16 | 1.25 Cr | 0.1158 |
| 2020-03-31 | 197.36 Cr | 187.23 Cr | 10.13 Cr | 0.0513 | 0.00 Cr | 0.00 Cr | 3.75 Cr | -0.56 Cr | -0.69 | 5.71 Cr | -0.0029 |
| 2019-03-31 | 167.52 Cr | 158.07 Cr | 9.44 Cr | 0.0564 | 0.00 Cr | 0.00 Cr | 5.56 Cr | 1.28 Cr | 1.57 | 7.31 Cr | 0.0076 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 0.26 Cr | 21.20 Cr | 10.33 Cr | 10.8649 Cr | 6.45 Cr | 6.19 Cr | 2.60 Cr | 14.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 6.9802 Cr |
| 2022-03-31 | 0.60 Cr | 20.70 Cr | 9.75 Cr | 10.9568 Cr | 6.14 Cr | 5.55 Cr | 1.74 Cr | 14.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 7.6102 Cr |
| 2021-03-31 | 0.18 Cr | 21.27 Cr | 9.91 Cr | 11.3555 Cr | 6.94 Cr | 6.77 Cr | 1.83 Cr | 14.81 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 7.8860 Cr |
| 2020-03-31 | 2.50 Cr | 116.52 Cr | 92.70 Cr | 23.8159 Cr | 19.57 Cr | 17.07 Cr | 49.96 Cr | 22.88 Cr | 0.00 Cr | 0.00 Cr | 0.94 Cr | 83.8271 Cr |
| 2019-03-31 | 2.14 Cr | 105.09 Cr | 79.99 Cr | 25.0939 Cr | 16.55 Cr | 14.40 Cr | 38.10 Cr | 21.82 Cr | 0.00 Cr | 0.00 Cr | 0.88 Cr | 72.1756 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | -0.6497 Cr | 0.0082 Cr | 1.3004 Cr | -0.6497 Cr | 0.6589 Cr | 0.6589 Cr | 0.0000 Cr | -0.0936 Cr | 0.0000 Cr | 0.0000 Cr | -0.8574 Cr |
| 2022-03-31 | 1.3418 Cr | -0.1253 Cr | 0.3352 Cr | 1.2165 Cr | 1.5517 Cr | 1.5517 Cr | -0.1253 Cr | -0.3987 Cr | 0.0000 Cr | 0.0000 Cr | 0.0908 Cr |
| 2021-03-31 | 17.1608 Cr | 0.0696 Cr | -8.9852 Cr | 17.1608 Cr | 8.2452 Cr | 8.2452 Cr | 0.0000 Cr | 0.9455 Cr | 0.0000 Cr | 0.0000 Cr | 48.0689 Cr |
| 2020-03-31 | 3.0184 Cr | -3.0932 Cr | -1.0468 Cr | -0.1018 Cr | -1.1216 Cr | -1.1216 Cr | -3.1202 Cr | -0.5639 Cr | 0.0000 Cr | 0.0000 Cr | -12.9436 Cr |
| 2019-03-31 | 3.3101 Cr | -3.2650 Cr | 0.3292 Cr | 0.1728 Cr | 0.3743 Cr | 0.3743 Cr | -3.1373 Cr | 1.2800 Cr | 0.0000 Cr | 0.0000 Cr | -12.9377 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | 0.26 Cr | 0.67 Cr | -0.41 Cr | -1.5710 | -0.96 Cr | -1.12 Cr | -1.38 | -0.90 Cr | -4.3157 |
| 2023-06-30 | 1.57 Cr | 0.96 Cr | 0.61 Cr | 0.3899 | 0.13 Cr | 0.02 Cr | 0.02 | 0.19 Cr | 0.0104 |
| 2023-03-31 | 1.46 Cr | 1.14 Cr | 0.32 Cr | 0.2164 | -0.09 Cr | -0.18 Cr | -0.22 | -0.06 Cr | -0.1214 |
| 2022-12-31 | 1.16 Cr | 0.29 Cr | 0.87 Cr | 0.7500 | 0.54 Cr | 0.46 Cr | 0.56 | 0.61 Cr | 0.3940 |
| 2022-09-30 | 0.79 Cr | 0.85 Cr | -0.06 Cr | -0.0749 | -0.30 Cr | 0.08 Cr | 0.10 | -0.23 Cr | 0.1027 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | 0.33 Cr | 0.00 Cr | 0.33 Cr | 0.49 Cr | 2.49 Cr | 3.72 Cr | 14.27 Cr | 18.23 Cr | 8.47 Cr |
| 2023-03-31 | 0.26 Cr | 0.00 Cr | 0.26 Cr | 3.53 Cr | 2.60 Cr | 6.54 Cr | 14.39 Cr | 21.20 Cr | 10.33 Cr |
| 2022-09-30 | 0.31 Cr | 0.00 Cr | 0.31 Cr | 2.85 Cr | 2.02 Cr | 5.39 Cr | 14.50 Cr | 20.18 Cr | 9.57 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,654.70 | ₹3,970,173,579,881.00 | ₹1,756,767.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,826.50 | ₹1,546,757,529,018.00 | ₹196,212.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,526.00 | ₹1,193,357,070,000.00 | ₹376,267.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,248.60 | ₹1,039,299,991,350.00 | ₹1,880,883.00 |
| Mankind Pharma Limited | MANKIND | ₹2,456.30 | ₹1,013,858,678,987.00 | ₹377,582.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹994.65 | ₹1,000,846,232,849.00 | ₹364,823.00 |
| Lupin Limited | LUPIN | ₹1,937.30 | ₹884,877,017,676.00 | ₹1,001,317.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,494.00 | ₹656,890,110,000.00 | ₹106,173.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,096.50 | ₹636,848,979,620.00 | ₹645,374.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,971.80 | ₹556,443,555,186.00 | ₹346,577.00 |
| Laurus Labs Limited | LAURUSLABS | ₹863.00 | ₹465,868,887,837.00 | ₹1,494,281.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,323.20 | ₹335,701,421,258.00 | ₹85,707.00 |
| Cohance Lifesciences Limited | COHANCE | ₹869.70 | ₹332,718,641,658.00 | ₹155,406.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,431.30 | ₹303,755,982,631.00 | ₹100,950.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,658.80 | ₹259,761,841,253.00 | ₹270,889.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,414.50 | ₹235,362,500,000.00 | ₹23,894.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,429.20 | ₹232,223,277,589.00 | ₹428,259.00 |
| Eris Lifesciences Limited | ERIS | ₹1,607.20 | ₹218,922,423,989.00 | ₹47,179.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹15,106.00 | ₹193,808,303,234.00 | ₹19,762.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹906.35 | ₹178,154,987,437.00 | ₹67,592.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,096.70 | ₹173,882,644,813.00 | ₹72,025.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,021.40 | ₹153,650,042,294.00 | ₹42,984.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹815.15 | ₹146,001,410,531.00 | ₹337,915.00 |
| Granules India Limited | GRANULES | ₹552.70 | ₹134,109,181,833.00 | ₹549,140.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,201.00 | ₹102,932,767,782.00 | ₹16,453.00 |
| Strides Pharma Science Limited | STAR | ₹834.10 | ₹76,881,260,747.00 | ₹283,085.00 |
| FDC Limited | FDC | ₹465.65 | ₹75,812,515,615.00 | ₹113,533.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹829.95 | ₹75,220,832,622.00 | ₹152,926.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹377.45 | ₹73,822,356,449.00 | ₹119,629.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.29 | ₹50,554,870,224.00 | ₹683,471.00 |
| Innova Captab Limited | INNOVACAP | ₹832.25 | ₹47,625,447,160.00 | ₹23,268.00 |
| Suven Life Sciences Limited | SUVEN | ₹209.40 | ₹45,657,721,952.00 | ₹147,288.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹499.30 | ₹45,571,111,000.00 | ₹135,801.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹131.91 | ₹42,807,642,673.00 | ₹181,574.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹742.50 | ₹37,658,935,463.00 | ₹61,065.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,252.40 | ₹37,252,477,386.00 | ₹5,835.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹354.70 | ₹35,570,204,878.00 | ₹16,230.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹487.00 | ₹34,287,600,250.00 | ₹11,723.00 |
| Hikal Limited | HIKAL | ₹253.10 | ₹31,207,419,825.00 | ₹196,519.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹103.87 | ₹30,488,702,464.00 | ₹1,844,372.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹48.73 | ₹26,701,783,752.00 | ₹1,385,993.00 |
| Alembic Limited | ALEMBICLTD | ₹102.14 | ₹26,227,695,912.00 | ₹175,157.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹612.00 | ₹26,173,985,400.00 | ₹53,814.00 |
| Indoco Remedies Limited | INDOCO | ₹284.00 | ₹26,173,839,020.00 | ₹31,975.00 |
Key Executives
No executive data available.
FAQs about Ortin Laboratories Limited
What is the current market price of the stock?
The current price is ₹22.34.
What is the 52-week price range?
The range is ₹22.27-23.31.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -194.08.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ortin Laboratories Limited (ISIN: INE749B01020) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹0.00 crores and an average daily volume of 0 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.